Neurologian yksikkö
Department of Neurology

Julkaisut 1999
Publications 1999

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alafuzoff I et al. Rapidly progressive multifocal leukoencephalopathy with substantial cell-mediated inflammatory response and with cognitive decline of non-Alzheimer type in a 75-year-old female patient.
2 Alafuzoff I et al. Beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients.
3 Alafuzoff I et al. Beta-amyloid load, astroglia and microglia in Alzheimer´s disease: association with apoE genotype.
4 Aura J, Riekkinen P Jr. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats.
5 Bayer TA et al. Neural expression profile of alpha-synuclein in developing human cortex.
6 Bayer TA et al. Alpha-synuclein accumulates in Lewy bodies in Parkinson´s disease and dementia with Lewy bodies but not in Alzheimer´s disease beta-amyloid plaque cores.
7 Björklund M et al. Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns.
8 Chadwick D, for the Vigabatrin European Monotherapy Study Group. Safety and efficscy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study.
9 Culvenor JG et al. Non-Abeta component of Alzheimer´s disease amyloid (NAC) revisited: NAC and alpha-synuclein are not associted with Abeta amyloid.
10 Eichenbaum H et al. The hippocampus, memory, and place cells: is it spatial memory or a memory space?
11 Eloniemi-Sulkava U et al. Support program for demented patients and their carers: the role of dementia family care coordinator is crucial.
12 Elovaara I et al. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection.
13 Everson SA et al. Anger expression and incident stroke: prospective evidence from the Kuopio Ischemic Heart Disease Study.
14 Ferguson GG et al. The North American Symptomatic Carotid Endarterectomy Trial surgical results in 1415 patients.
15 Frisoni GB et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer´s disease.
16 Geroldi C et al. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.
17 Helenius M et al. Attenuation of NF-kappaB signaling response to UVB light during cellular senescence.
18 Helisalmi S et al. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer´s disease patients and control individuals.
19 Hiltunen M et al. Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer`s disease patients.
20 Holmberg M et al. Adrenergic alpha2C-receptors reside in rat striatal gabaergic projection neurons: comparison of radioligand binding and immunohistochemistry.
21 Hänninen T et al. Kognitiiviset testit muistihäiriöiden ja alkavan dementian varhaisdiagnostiikassa: CERAD-tehtäväsarja.
22 Hänninen T, Soininen H. Lievä kognitiivinen heikentyminen dementian varhaisena merkkinä.
23 Ihalainen JA et al. Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysis.
24 Ikonen S, Riekkinen P Jr. Effects of apamin on memory processing of hippocampal-lesioned mice.
25 Ikonen S et al. Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice.
26 Jagger C et al. Prognosis with dementia: results from a European collaborative analysis of population-based studies.
27 Jolkkonen J et al. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
28 Juottonen K et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease.
29 Jäkälä P et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans.
30 Jäkälä P et al. Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers.
31 Jäkälä P et al. Guanfacine and clonidine, alpha2-agonists, improve paired associates learning, but not delayed matching to sample, in humans.
32 Kappelle LJ et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery.
33 Karonen JO et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke: ischemic penumbra predicts infarct growth.
34 Kyrylenko S et al. Regulation of PTEN expression in neuronal apoptosis.
35 Kälviäinen R. Cognitive effects of GABAergic antiepileptic drugs.
36 Kälviäinen R et al. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects.
37 Kälviäinen R, Pitkänen A. Prevention of seizure-induced neuronal damage and intellectual deterioration: experimental aspects and clinical implications.
38 Launer LJ et al. Regional differences in the incidence of dementia in Europe: EURODEM collaborative analyses.
39 Lauri SE et al. Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation.
40 Luostarinen L et al. Coeliac disease presenting with neurological disorders.
41 Makkonen N et al. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
42 Mikkonen M. The Human Entorhinal Cortex . Anatomic Organization and Its Alteration in Alzheimer's Disease and Temporal Lobe Epilepsy.
43 Mikkonen M et al. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28k immunoreactivity in the entorhinal cortex in Alzheimer`s disease.
44 Mikkonen M et al. Hippocampal plasticity in Alzheimer´s disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation.
45 Overmyer M et al. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.
46 Overmyer M et al. Astrogliosis and the ApoE genotype: an immunohistochemical study of postmortem human brain tissue.
47 Pitkänen A, Jolkkonen J. Do GABAergic circuitries play a critical role in the regulation of seizure-induced neuronal damage and synaptic reorganization in the rat hippocampus?
48 Pitkänen A et al. Seizure-induced damage to the medial temporal lobe in temporal lobe epilepsy.
49 Puoliväli J et al. Moderate cortical EEG changes in apolipoprotein E-deficient mice during ageing and scopolamine treatment but not after nucleus basalis lesion.
50 Pussinen R. An Experimental Study on the Role of alfa1-Adrenoceptors and Putrescine in the Modulation of Hippocampal Plasticity and Memory Encoding - Interactions with NMDA Receptors.
51 Puumala T. Monoamines in the Modulation of Attention and Response Inhibition:Development of a New Animal Model of Attention Deficit and Impulsivity.
52 Riekkinen M et al. The alpha2 agonist, clonidine, improves spatial working memory performance in Parkinson´s disease.
53 Riekkinen M et al. Clonidine impairs sustained attention in Alzheimer´s disease.
54 Riekkinen M et al. Clonidine impairs sustained attention and memory in Alzheimer´s disease.
55 Riekkinen M, Riekkinen P Jr. Alpha2-adrenergic agonis clonidine for improving spatial working memory in Parkinson´s disease .
56 Riekkinen P Jr et al. Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water maze spatial navigation defect induced by hippocampal inactivation.
57 Riekkinen P Jr, Riekkinen M. THA improves word priming and clonidine enhances fluency and working memory in Alzheimer´s disease.
58 Rissanen A et al. In mice tonic estrogen replacement therapy improves non-spatial and spatial memory in a water maze task.
59 Roivainen R et al. Aivo-, kaula- ja nikamavaltimo-ahtaumien suonensisäinen hoito.
60 Ropponen KM, Alafuzoff I. A case of sudden death caused by fibromuscular dysplasia.
61 Rothwell PM et al. Interpretation of operative risks of individual surgeons.
62 Rothwell PM et al. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study.
63 Sivenius J. Comment to (Extended-release dipyridamole/aspirin).
64 Sivenius J. Aivohalvauspotilaan hoidon periaatteet.
65 Sivenius J et al. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age.
66 Sivenius J et al. Antiplatelet treatment does not reduce the severity of subsequent stroke.
67 Soininen H, Hänninen T. Kuka on vaarassa sairastua Alzheimerin tautiin ?
68 Soininen HS, Riekkinen P Sr. APOE type and MRI volumetric changes as predictor of Alzheimer´s disease.
69 Solovyan V et al. Distinct mechanisms underlay DNA disintegration during apoptosis induced by genotoxic and nongenotoxic agents in neuroblastoma cells .
70 Solovyan V, Salminen A. A rapid and efficient method for preparation of genomic DNA suitable for analysis of both high and low molecular weight DNA fragmentation during neuronal apoptosis.
71 Tanila H. Vanhenevat aivot, huononeva muisti.
72 Tanila H. Hippocampal place cells can develop distinct representations of two visually identical environments.
73 Tanila H et al. Role of alfa2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alfa2C-adrenoceptor gene.
74 Tapiola T et al. Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer´s disease.
75 Taylor DW et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial.
76 Vanhanen M et al. Type-2 diabetes and cognitive function in a non-demented population.
77 Wegiel J et al. Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome.
78 Wilson IA et al. Estrogen and NMDA receptor antagonism: effects upon reference and working memory.
79 Ylinen A et al. Long-term treatment with vigabatrin - 10 years of clinical experience.
80 Äikiä M et al. Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008